Investigación > Cáncer

Patología oncológica

Número de publicaciones
572
Buscador de publicaciones

  • De Petris, G.; Gatius Caldero, S.; Chen, L.; Xiao, S.-Y.; Dhungel, B.M.; Wendel Spizcka, A.J.; Lam-Himlin, D.

    Histopathological Changes in the Gastrointestinal Tract Due to Drugs: An Update for the Surgical Pathologist ( Part I of II)

    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY 22 120-128. .

    [doi:10.1177/1066896913502229]

  • Eritja N; Domingo M; Dosil MA; Mirantes C; Santacana M; Valls J; Llombart-Cussac A; Matias-Guiu X; Dolcet X

    Combinatorial Therapy Using Dovitinib and ICI182.780 (Fulvestrant) Blocks Tumoral Activity of Endometrial Cancer Cells

    MOLECULAR CANCER THERAPEUTICS 13 776-787. .

    [doi:10.1158/1535-7163.MCT-13-0794]

  • Espinosa, I; Catasus, L; D' Angelo E; Mozos, A; Pedrola, N; Bertolo, C; Ferrer, I; Zannoni, GF; West, RB; van de Rijn, M; Matias-Guiu, X; Prat, J

    Stromal signatures in endometrioid endometrial carcinomas

    Modern Pathology 27 631-639. .

    [doi:10.1038/modpathol.2013.131]

  • Bergadà L; Yeramian A; Sorolla A; Matias-Guiu X; Dolcet X

    Antioxidants Impair Anti-Tumoral Effects of Vorinostat, but Not Anti-Neoplastic Effects of Vorinostat and Caspase-8 Downregulation

    PLOS ONE 9 -. .

    [doi:10.1371/journal.pone.0092764]

  • Matias-Guiu X; De Lellis R

    Medullary Thyroid Carcinoma: a 25-Year Perspective

    ENDOCRINE PATHOLOGY 25 21-29. .

    [doi:10.1007/s12022-013-9287-2]

  • Matias-Guiu X; Davidson B

    Prognostic biomarkers in endometrial and ovarian carcinoma

    VIRCHOWS ARCHIV 464 315-331. .

    [doi:10.1007/s00428-013-1509-y]

  • Maiques O; Santacana M; Valls J; Pallares J; Mirantes C; Gatius S; García Dios DA; Amant F; Pedersen HC; Dolcet X; Matias-Guiu X

    Optimal protocol for PTEN immunostaining; role of analytical and preanalyticat variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues

    HUMAN PATHOLOGY 45 522-532. .

    [doi:10.1016/j.humpath.2013.10.018]

  • García-Carbonero R; Vilardell F; Jiménez-Fonseca P; González-Campora R; González E; Cuatrecasas M; Capdevila J; Aranda I; Barriuso J; Matías-Guiu X

    Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    CLINICAL & TRANSLATIONAL ONCOLOGY 16 243-256. .

    [doi:10.1007/s12094-013-1062-9]

  • Barcelo C; Paco N; Morell M; Alvarez-Moya B; Bota-Rabassedas N; Jaumot M; Vilardell F; Capella G; Agell N

    Phosphorylation at Ser-181 of Oncogenic KRAS Is Required for Tumor Growth

    CANCER RESEARCH 74 1190-1199. .

    [doi:10.1158/0008-5472.CAN-13-1750]

  • Bergada, L; Santacana, M; Garcia, V; Carceller, JA; Dolcet, X; Matias-Guiu, X

    Role of Y-H2AX Expression in Prediction of Radiation Resistance in Endometrial Carcinoma

    LABORATORY INVESTIGATION 94 276-276. .

  • Santacana, M; Maiques, O; Valls, J; Gatius, S; Lopez-Garcia, MA; Palacios, J; Dolcet, X; Matias-Guiu, X

    Immunohistochemical Profiling in Assessing Histological Type in Endometrial Carcinoma

    Modern Pathology 27 304-304. .

  • Macià A; Vaquero M; Gou-Fàbregas M; Castelblanco E; Valdivielso JM; Anerillas C; Mauricio D; Matias-Guiu X; Ribera J; Encinas M

    Sprouty1 induces a senescence-associated secretory phenotype by regulating NFjB activity: implications for tumorigenesis

    CELL DEATH AND DIFFERENTIATION 21 333-343. .

    [doi:10.1038/cdd.2013.161]